Get the Stockscreener App
6.00
0.66%
-0.04
Tenax Therapeutics Inc stock is traded at $6.00, with a volume of 7,744.
It is down -0.66% in the last 24 hours and down -0.33% over the past month.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
See More
Previous Close:
$6.04
Open:
$6.05
24h Volume:
7,744
Relative Volume:
0.30
Market Cap:
$27.38M
Revenue:
-
Net Income/Loss:
$-14.56M
P/E Ratio:
-0.3567
EPS:
-16.82
Net Cash Flow:
$-12.46M
1W Performance:
+0.50%
1M Performance:
-0.33%
6M Performance:
-11.11%
1Y Performance:
+39.21%
1-Day Range:
$5.9101
$6.05
1-Week Range:
$5.8418
$6.05
52-Week Range:
$3.25
$7.89
Tenax Therapeutics Inc Stock (TENX) Company Profile
Name
Tenax Therapeutics Inc
Sector
Industry
Phone
919-855-2100
Address
101 GLEN LENNOX DRIVE, CHAPEL HILL, NC
Compare TENX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TENX
Tenax Therapeutics Inc
|
6.00 | 24.93M | 0 | -14.56M | -12.46M | -16.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Tenax Therapeutics Inc Stock (TENX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-24-24 | Initiated | Leerink Partners | Outperform |
| Oct-14-24 | Initiated | Guggenheim | Buy |
| Sep-30-24 | Initiated | William Blair | Outperform |
| May-18-17 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Dec-16-14 | Initiated | MLV & Co | Buy |
| Nov-18-14 | Initiated | WallachBeth | Buy |
View All
Tenax Therapeutics Inc Stock (TENX) Latest News
Will Tenax Therapeutics Inc. continue its uptrendWeekly Earnings Recap & Technical Entry and Exit Alerts - Newser
Tenax Therapeutics Inc. Included in Top Momentum ScanJuly 2025 Final Week & Step-by-Step Swing Trade Plans - beatles.ru
Can a trend reversal in Tenax Therapeutics Inc. lead to recovery2025 Volume Leaders & Smart Allocation Stock Tips - Newser
Tenax Therapeutics Inc. Price Targets Raised After Rebound2025 Trading Recap & Advanced Swing Trade Entry Alerts - classian.co.kr
Is Tenax Therapeutics Inc. stock reversal real or fake2025 Market Sentiment & Weekly Watchlist for Hot Stocks - Newser
Tools to assess Tenax Therapeutics Inc.’s risk profile2025 Short Interest & Reliable Momentum Entry Alerts - Newser
Does Tenax Therapeutics Inc. show high probability of rebound2025 EndofYear Setup & Verified Trade Idea Suggestions - Newser
Multi factor analysis applied to Tenax Therapeutics Inc.Product Launch & Fast Exit/Entry Strategy Plans - Newser
Advanced analytics toolkit walkthrough for Tenax Therapeutics Inc.Gold Moves & Real-Time Price Movement Reports - Newser
Tenax Therapeutics Inc. stock momentum explained2025 Market Trends & Accurate Buy Signal Alerts - Newser
What indicators show strength in Tenax Therapeutics Inc.2025 Investor Takeaways & Safe Capital Growth Plans - Newser
Using portfolio simulators with Tenax Therapeutics Inc. includedQuarterly Trade Report & Weekly Momentum Picks - Newser
Will Tenax Therapeutics Inc. benefit from macro trendsJuly 2025 Catalysts & Smart Investment Allocation Insights - Newser
Tenax Therapeutics Inc. stock trendline breakdown2025 Geopolitical Influence & Fast Entry Momentum Trade Alerts - Newser
How to use Fibonacci retracement on Tenax Therapeutics Inc.Gap Up & Fast Entry Momentum Trade Alerts - Newser
Does Tenax Therapeutics Inc. fit your quant trading model2025 Fundamental Recap & Expert Curated Trade Setup Alerts - Newser
Is Tenax Therapeutics Inc. reversing from oversold territory2025 Geopolitical Influence & Free Technical Pattern Based Buy Signals - Newser
Using RSI to spot recovery in Tenax Therapeutics Inc.2025 Historical Comparison & Free Growth Oriented Trading Recommendations - Newser
Trapped Investors in Tenax Therapeutics Inc. Await Breakout SignalJuly 2025 Retail & Verified Technical Trade Signals - 선데이타임즈
Q3 EPS Forecast for Tenax Therapeutics Lowered by Analyst - Defense World
Breakout Traders Target Tenax Therapeutics Inc. on Recovery SetupForecast Cut & Reliable Volume Spike Alerts - 선데이타임즈
Leerink Partnrs Issues Negative Forecast for TENX Earnings - Defense World
Roth Capital Issues Negative Outlook for TENX Earnings - Defense World
Developing predictive dashboards with Tenax Therapeutics Inc. data2025 Top Gainers & Verified Short-Term Trading Plans - Newser
Order flow analysis tools used on Tenax Therapeutics Inc.Portfolio Return Summary & Expert-Curated Trade Recommendations - Newser
Published on: 2025-08-17 12:19:10 - beatles.ru
Published on: 2025-08-17 03:18:54 - Newser
Guggenheim Cuts Tenax Therapeutics (NASDAQ:TENX) Price Target to $14.00 - Defense World
Multi Factor Analysis Ranks Tenax Therapeutics Inc. as Strong Buy2025 Sector Review & Detailed Earnings Play Alerts - newsyoung.net
Statistical indicators supporting Tenax Therapeutics Inc.’s strengthM&A Rumor & Weekly High Conviction Ideas - Newser
Relative strength of Tenax Therapeutics Inc. in sector analysisCPI Data & Capital Protection Trade Alerts - Newser
Earnings Chart Overlay Points to Tenax Therapeutics Inc. Upside2025 Year in Review & Capital Protection Trade Alerts - metal.it
Visual analytics tools that track Tenax Therapeutics Inc. performanceTrade Risk Report & Fast Exit/Entry Strategy Plans - Newser
Published on: 2025-08-16 02:08:37 - Newser
Tenax Therapeutics Inc Stock (TENX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):